ACTIVX

Serial Number 78413910
Registration 3059588
800

Registration Progress

Application Filed
May 6, 2004
Under Examination
Jun 7, 2005
Approved for Publication
Feb 23, 2005
Published for Opposition
Mar 15, 2005
Registered
Feb 14, 2006

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20060214)
Due: Feb 14, 2026 6 days

Trademark Image

ACTIVX

Basic Information

Serial Number
78413910
Registration Number
3059588
Filing Date
May 6, 2004
Registration Date
February 14, 2006
Published for Opposition
March 15, 2005
Renewal Date
February 14, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 22, 2016
Registration
Registered
Classes
042

Rights Holder

ActivX Biosciences, Inc.

03
Address
11025 N. Torrey Pines Road
La Jolla, CA 92037

Ownership History

ActivX Biosciences, Inc.

Original Applicant
03
La Jolla, CA

ActivX Biosciences, Inc.

Owner at Publication
03
La Jolla, CA

ActivX Biosciences, Inc.

Original Registrant
03
La Jolla, CA

USPTO Deadlines

Next Deadline
6 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20060214)
Due Date
February 14, 2026
Grace Period Ends
August 14, 2026

Application History

32 events
Date Code Type Description Documents
Feb 14, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Apr 22, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Apr 22, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Apr 22, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 22, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 16, 2016 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Feb 16, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 14, 2015 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Nov 19, 2012 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Nov 19, 2012 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Oct 17, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 6, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 1, 2012 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Feb 14, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 4, 2006 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED Loading...
Dec 30, 2005 ALIE A ASSIGNED TO LIE Loading...
Dec 29, 2005 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 6, 2005 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 15, 2005 IUAF S USE AMENDMENT FILED Loading...
Nov 15, 2005 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 1, 2005 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 1, 2005 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 7, 2005 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 15, 2005 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 23, 2005 NPUB O NOTICE OF PUBLICATION Loading...
Dec 30, 2004 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 27, 2004 ALIE A ASSIGNED TO LIE Loading...
Dec 20, 2004 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 20, 2004 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 20, 2004 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 6, 2004 DOCK D ASSIGNED TO EXAMINER Loading...
May 12, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development services, namely, laboratory research and monitoring of clinical trials for diagnostic tests for drug screening, instruments for drug screening, and pharmaceuticals, laboratory research and monitoring of clinical trials in the field of activity-based proteomics scientific and technological services for applying proprietary chemical technologies and high-throughput protein analysis to drug discovery processes and research and design relating thereto, scientific and technological services for drug development and discovery, scientific and technological services for addressing disease mechanisms with focus on functional proteins and research and design relating thereto, scientific and technological services for selectivity profiling drug candidates across protein families in biological samples to guide their medicinal chemistry optimization and research and design relating thereto, scientific and technological services to identify novel drug targets and biomarkers and research and design relating thereto, and scientific and technological services to characterize off-target activities of candidate and established drugs to understand the basis for their efficacy and toxicity and research and design relating thereto
First Use Anywhere: Jul 23, 2001
First Use in Commerce: Jul 23, 2001

Classification

International Classes
042